July/August/September 2025

Volume 26 Issue 3

Browse other issues »Subscribe to our print issues »Download Issue »

Articles in this Issue

How Tariffs Could Impact Your Drug Development Supply Chain: Top Five Things to Be Aware Of

The pharmaceutical industry is entering a period of intensified trade disruption. With new tariffs on imported raw materials, active pharmaceutical ingredients (APIs), and medical components, global ... read more
Beyond Wearables: How Integrated BGM + eCOA Solutions are Solving Real World Problems in Obesity...

In today’s highly connected healthcare ecosystem, wearable technology and electronic Clinical Outcome Assessments (eCOA) are converging to create new and unique opportunities for patient empowerment ... read more
Challenges in Developing Analytical Procedures with the New ICH Q14 Guideline

The current effective version of ICH Q14-Analytical Procedure Development was adopted on 1 November 2023. Development of analytical procedures under the new ICH Q14 guideline poses significant ... read more
Optimizing Product Packaging and Oral Drug Delivery with Stick Packs

In the ever-evolving world of pharmaceutical science, innovation in drug delivery systems often drives improvements in patient adherence, therapeutic efficacy, and manufacturing efficiency. One such ... read more
PV Automation Next Steps: Solving the Significant Headache of Local Literature Monitoring

Medical literature monitoring is a key part of pharmacovigilance (PV) and ultimately patient safety across the lifecycle of a medicine. Globally, the practice is relatively straightforward, but up to ... read more
An ADME Guide for Successful siRNA Therapeutics: Insights from Approved Drugs

Small interfering RNA (siRNA) therapeutics have emerged as a trans formative class of drugs, offering targeted gene silencing capabilities that hold promise for treating various diseases. Since the ... read more
Why Pharma AI Projects Fail: The Human Problem Behind Technical Success

Artificial intelligence (AI) is one of the most talked-about tools in the pharmaceutical world, not because of hype, but because of its practical potential. But repeatedly, promising projects stall - ... read more
A Critical Inflexion Point: The Indisputable Case for Next-Gen Pharmacovigilance

Adverse event case processing is an enormous cost center and compliance issue for life sciences. As revenues stagnate for many pharma companies and profits come under new pressures, the expectation to... read more
The Dog Days of Summer

As I write this in the middle of August, during an oppressively humid heat wave, the term “the dog days of summer” comes to mind. If you have never heard that term, it refers to the hottest, most ... read more